Results 161 to 170 of about 12,736,036 (293)

Recombinant factor VIIa: use in fatal post partum hemorrhage — Indian experience case series and review of literature [PDF]

, 2009
Shailesh R. Singi, Evita Fernandez, Sunil Pandya, H. R. Badrinath   +3 more
openalex   +1 more source

Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions

The Turkish Journal of Pediatrics, 2003
Transfusion of platelet concentrates remains the first-line therapy for Glanzmann thrombasthenia in case of bleeding or preparation for surgery. However, development of antibodies to platelet glycoprotein (Gp) IIb/IIIa complex or human leukocyte ...
Omer Devecioğlu, Ayşegül Unüvar, Sema Anak, Ilmay Bilge, Haluk Ander, Orhan Ziylan   +5 more
doaj  

A systematic approach for evaluating the role of surface-exposed loops in trypsin-like serine proteases applied to the 170 loop in coagulation factor VIIa. [PDF]

Sci Rep, 2022
Sorensen AB, Greisen PJ, Madsen JJ, Lund J, Andersen G, Wulff-Larsen PG, Pedersen AA, Gandhi PS, Overgaard MT, Østergaard H, Olsen OH.   +10 more
europepmc   +1 more source

Tissue factor activates allosteric networks in factor VIIa through structural and dynamic changes

Journal of Thrombosis and Haemostasis, 2015
Jesper J. Madsen, Jesper J. Madsen, E. Persson, O. H. Olsen   +3 more
semanticscholar   +1 more source

A serine loop in tissue factor mediates substrate selectivity by the tissue factor-factor VIIa complex. [PDF]

J Thromb Haemost, 2021
Birkle F, Morrissey JH.
europepmc   +1 more source

Commentary on “Therapeutic doses of recombinant factor VIIa in hemophilia generates thrombin in platelet‐dependent and ‐independent mechanisms” [PDF]

, 2020
Bjarne Østerud
openalex   +1 more source

Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: The experience of the Hemostasis and Thrombosis Research Society (HTRS) Registry (2004–2008) [PDF]

, 2013
Ellis J. Neufeld, Kapil Saxena, Craig M. Kessler, David L. Cooper, on behalf of the HTRS Investigators   +4 more
openalex   +1 more source

Intrapulmonary Recombinant Factor VIIa for Diffuse Alveolar Hemorrhage in Children

Pediatrics, 2015
J. Park, Byoung-ju Kim
semanticscholar   +1 more source

Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial. [PDF]

Int J Stroke, 2022
Naidech AM, Grotta J, Elm J, Janis S, Dowlatshahi D, Toyoda K, Steiner T, Mayer SA, Khanolkar P, Denlinger J, Audebert HJ, Molina C, Khatri P, Sprigg N, Vagal A, Broderick JP.   +15 more
europepmc   +1 more source

Use of Recombinant Factor VIIa Utilization Among a Hospitalized Pediatric Population [PDF]

, 2015
Nathan E. Thompson, Melissa Meuler, John P. Scott   +2 more
openalex   +1 more source